Study focuses on prescription addiction

Apr 23, 2007

Researchers at the University of California-San Francisco have started a study to evaluate treatments for addiction to prescription painkillers.

The research is the first large-scale study designed to assess whether addiction to opioid painkillers, such as Vicodin and OxyContin, can effectively be treated with drug treatments currently used for heroin addiction.

The study -- part of a national effort involving 11 clinical research centers -- is in response to increasing incidents of prescription drug abuse, said to Dr. Stephen Dominy of the San Francisco General Hospital Medical Center, who is co-leading the University of California-San Francisco portion of the study.

"The abuse of prescription opiates has become a very serious problem in our society but, until now, there have been no large-scale studies to evaluate how to treat those addictions," Dominy said. "This study hopes to assess whether current opiate dependence therapies are effective, as well as the role of counseling in treatment outcomes."

Copyright 2007 by United Press International

Explore further: First clinical trial for new skin wound-healing compound is a success

add to favorites email to friend print save as pdf

Related Stories

Study: More can be done more to help smokers quit

Jun 15, 2010

(PhysOrg.com) -- Many healthcare providers are quick to advise patients to quit smoking, but few follow up with programs, plans or prescriptions to help them break the habit, new research from UC Davis has found.

AMD drug and IOP; getting good eyeglasses to those in need

Oct 26, 2009

A first-time finding of intraocular pressure increases in patients with no personal or family history of glaucoma following anti-VEGF treatment for wet age-related macular degeneration (AMD), and a report on a simple, low-cost ...

Recommended for you

Boxed warnings are common in novel therapeutics

Aug 19, 2014

(HealthDay)—Boxed warnings are common on recent drug approvals, and many occur years after approval, according to a research letter published online Aug. 15 in JAMA Internal Medicine.

AstraZeneca says DOJ closes probe into drug trial

Aug 19, 2014

British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action.

User comments : 0